Full-Time

Customer Care Specialist

Confirmed live in the last 24 hours

Axogen

Axogen

201-500 employees

Compensation Overview

$22 - $24/hr

+ Bonus

Entry, Junior

Alachua, FL, USA

Category
Customer Experience & Support
Customer Support
Requirements
  • High School Diploma or equivalent, AA degree preferred
  • Proficient using Microsoft Office applications
  • Detailed oriented
  • Excellent problem-solving skills
  • Effective time management and organizational skills
  • Able to train Mon-Fri 9am - 6pm for 1 month then work Mon-Fri, 11am - 8pm and work on call as needed on the weekends (usually once every few months)
Responsibilities
  • Coordinates customer interactions in a professional manner that positively represents Axogen Inc.
  • Supports the Customer Care Department with administrative tasks such as data entry, filing and answering phones.
  • Information will be provided about products and services and could include obtaining details of complaints in accordance with established regulations and procedures.
  • Keeps records of customer interactions and transactions, recording details of inquiries, complaints and comments as well as actions taken
  • Ensures appropriate actions were taken to promptly resolve customers’ problems. Documents actions taken and provide solutions to possible avoid future occurrences.
  • Contacts customers to respond to inquiries; notify them of claim investigation results and any planned adjustments
  • Refers unresolved customer grievances to designated departments for further investigation
  • Determines charges for services requested and arrange for billing
  • Completes contract forms, prepares change of address records, and issues service consignment discontinuance orders
  • Coordinates with customers on inventory and shipments of product
  • Collaborates effectively with sales and other departments ensuring world class customer care is consistently achieved
  • Complies with all company policies, procedures and SOPs

Company Size

201-500

Company Stage

IPO

Headquarters

Alachua, Florida

Founded

2002

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven surgical solutions could enhance Axogen's market position.
  • Personalized medicine trend allows Axogen to develop customized nerve repair solutions.
  • Telemedicine rise enables Axogen to offer post-surgical care solutions.

What critics are saying

  • Emerging biotech competition may impact Axogen's market share.
  • FDA approval delays could affect Avance Nerve Graft's launch timelines.
  • Stock dilution from public offering may affect shareholder value.

What makes Axogen unique

  • Axogen leads in innovative surgical solutions for peripheral nerve injuries.
  • Avive+ Soft Tissue Matrix offers unique temporary protection during nerve healing.
  • Axogen's rolling BLA submission for Avance Nerve Graft marks a regulatory milestone.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Employee Stock Purchase Plan

Tuition Reimbursement

Paid Parental Leave

Paid Caregiver Leave

Basic Life Insurance

Supplemental Life Insurance

Disability Insurance

Company News

Health Promo
Mar 26th, 2025
Axogen Announces Appointment of Rick Ditto as Vice

ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy.

Market Wire News
Jan 10th, 2025
AXGN - Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations.

Investor Brand Network
Nov 7th, 2024
BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Strengthens Clinical Research Team with Appointment of Senior Clinical Scientist

Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair.

MedTech Dive
Aug 9th, 2024
Axogen names ex-Abbott exec Michael Dale as CEO

Axogen names ex-abbott exec Michael Dale as CEO.

GlobeNewswire
Jun 24th, 2024
Axogen, Inc Announces Full Launch Of Avive+ Soft Tissue Matrix(Tm)

ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing. Avive+ is processed and distributed in accordance with U.S. Food and Drug Administration (FDA) requirements for Human Cellular and Tissue-based Products (HCT/P) under 21 CFR Part 1271 regulations, U.S